化合物 T11751 T11751

Product Introduction
Bioactivity


英文名: KDOAM-25

描述: KDOAM-25, a potent and highly selective inhibitor of histone lysine demethylases 5 (KDM5) with IC50 values of 71 nM for KDM5A, 19 nM for KDM5B, 69 nM for KDM5C, and 69 nM for KDM5D, enhances global H3K4 methylation at transcriptional start sites and reduces proliferation in multiple myeloma MM1S cells.

体外活性: KDOAM-25 treatment results in a G1 cell-cycle arrest with an increased proportion of MM1S in G1 and a decrease of the proportion of cells in G2 without an increase in the proportion of cells in the apoptotic sub-G1 phase. KDOAM-25 (50 μM) increases with approximately twice as much H3K4me3 in in multiple myeloma cells. KDOAM-25 inhibits most potently KDM5B with an IC50 of ～50 μM and the other KDM5 family members at concentrations above 100 μM. KDOAM-25 shows no cellular activity on any of the other tested JmjC family members. KDOAM-25 is able to reduce the viability of MM1S cells with an IC50 of ～30 μM after a delay of 5-7 days.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

关键字: KDOAM25 | KDOAM 25 | KDOAM-25

相关产品: Dehydroacetic acid | Apramycin sulfate | Pogostone | Ethambutol dihydrochloride | Syringic acid | Q203 | Benzoylacetone | Cefotiam Hexetil Hydrochloride | Sanguisorbigenin | Lysozyme from chicken egg white

化合物 T11751 T11751信息由TargetMol中国为您提供，如您想了解更多关于化合物 T11751 T11751报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途